CoAlign Innovations landed a nod from federal regulators for the XL version of its AccuLIF device, used during spine fusion surgeries.

CoAlign’s interbody implant is used during the lateral approach to spine surgery, a less-invasive method than traditional posterior fusion or anterior fusion techniques. During lateral surgery, the AccuLIF device is placed inside the target spine section before expanding to create an accurate reconstruction of proper spine anatomy, according to a press release.

The XL size is the latest in a line of AccuLIF products. The Redwood City, Calif.-based company said it will be announcing other versions of the AccuLIF line in upcoming months.  

AccuLIF products are designed to restore the spine’s natural curve. The XL size still allows surgeons to insert the device in a compact form, and then expands to appropriate size for larger patients, according to the release.

"Because the lateral approach represents such a large and growing portion of the spine market, we are very excited to add the XL device to the AccuLIF family," executive chairman Paul Goeld said in prepared remarks.